OHSU findings may improve how people with chronic heartburn, precancer of the esophagus are screened

December 04, 2006

Researchers in the Oregon Health & Science University Digestive Health Center are first to report that screening people with chronic heartburn or pre-cancer of the esophagus in an office setting using a "skinny scope" is as accurate, less expensive and less risky than a traditional sedated screening in a procedure room -- and patients prefer it. The findings are published online and in print in this month's issue of the American Journal of Gastroenterology.

The study, led by principal investigator Blair A. Jobe, M.D., a surgeon in the OHSU Digestive Health Center and member of the OHSU Cancer Institute, found that study participants preferred unsedated, small-caliber upper endoscopy, commonly referred to as the skinny scope, to the standard screening method for upper digestive disease, sedated upper endoscopy.

Study participants in Jobe's Esophageal Care Clinic listed a number of reasons for preferring the skinny scope, including not having to undergo anesthesia, not missing a day of work and not having to arrange for transportation to and from home. But the best benefit, according to at least one study participant, was the ability to watch the entire procedure in real time on a color monitor and receive immediate feedback from the clinician.

"There was no pain. My wife and I watched the entire thing. I found it informative and appreciated not having to wait for the anesthesia to wear off to learn the results," said Dennis Murphy, 58, Tigard, Ore. Murphy was diagnosed with Barrett's esophagus, a precursor to cancer, four years ago. As part of the study protocol, he underwent both procedures on separate occasions. At the end of the study, he said he preferred the skinny scope and would request it at his next checkup.

With approximately 10 million Americans struggling with chronic heartburn, also known as GERD (gastroesophageal reflux disease) -- a condition closely associated with the development of one of the most lethal forms of cancer: esophageal cancer -- the need for a cost-effective screening and surveillance system was long apparent to Jobe, who also is an associate professor of surgery in the OHSU School of Medicine, Portland Veterans Affairs Medical Center.

"However, given the relative rarity of esophageal cancer compared with the high prevalence of GERD," Jobe explained. "Routine screening within the general population using traditional upper endoscopy would be too costly."

Eager to find an economically viable means of screening and monitoring this patient population, Jobe and colleagues endeavored to devise a method that would reduce the cost, inconvenience and complications associated with sedated endoscopy -- and they succeeded.

"This trial has established that unsedated small-caliber endoscopy used in an office setting is technically feasible, well-tolerated and accurate in the screening and diagnosis of Barrett's esophagus. It's a more personal approach and represents the potential to eliminate the infrastructure and costs required for intravenous sedation. It's also more immediate. As soon as you're done, you can tell the patient what you've found."

To perform a sedated upper endoscopy, an endoscope, 9.8 mm in diameter, is passed through the mouth and throat to the esophagus, stomach and small intestine. The procedure requires the resources and infrastructure of an outpatient procedure unit, two assistants, intravenous sedation and post-procedure monitoring, with a total cost in the thousands of dollars. And, as with any procedure for which the patient is sedated, the risk of complications, though rare, is higher.

By comparison, the skinny scope procedure is performed by a single clinician in an office setting and does not require sedation. Patients inhale a topical anesthetic that numbs their nasal passages and throat. The clinician then passes a smaller-caliber endoscope, 4.9 mm in diameter, through the nose, pharynx and throat. The cost for this procedure is in the hundreds of dollars.

Only a handful of centers in the United States routinely employ the skinny scope as part of clinical practice. According to Jobe, this is due in part to the perception that the unsedated skinny scope increases patient anxiety and discomfort. In addition, some endoscopists, unfamiliar with the nasal approach, may lack the skills necessary to perform it. And, up until recently, endoscopes were not long enough to examine the entire upper digestive tract.

One hundred thirty-four men and women with long-standing histories of GERD symptoms and acid-reducing medication use were enrolled in this randomized, cross-over trial. Ninety-eight percent of subjects successfully completed unsedated small-caliber endoscopy (skinny scope) in an office setting. More than 70 percent of participants said they would choose the unsedated skinny scope over the conventional approach on a subsequent endoscopy. The prevalence of Barrett's esophagus discovered by both approaches was equal and there were no undetected cases of cancer.
-end-
The National Institutes of Health supported this research.

ABOUT ESOPHAGEAL CANCER

The National Cancer Institute estimates 13,200 Americans will be diagnosed with esophageal cancer this year and 12,500 will die of the malignancy. Of the new cases, 9,200 will occur in men and 3,100 will occur in women. An estimated 25 million Americans have some form of esophageal disease, the most common of which is gastroesophageal reflux disease (GERD). Patients with severe GERD have a 40 times greater risk of developing esophageal cancer than those without GERD symptoms, a risk similar to that of a cigarette smoker developing lung cancer. That said, for one particular individual with GERD, the risk of esophageal cancers is quite low.

Oregon Health & Science University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.